SEMA4C promotes oncogenic signaling in breast cancer, hepatocellular cancer, and osteosarcoma, it also regulates proliferation, migration, lymphangiogenesis, and metastasis of cancer cells [14, 16–18, 20, 22]. This evidence concerns the gene SEMA4C and breast carcinoma.